Tonix Pharmaceuticals Holding Corp. (TNXP)
15.14
+0.04
(+0.26%)
USD |
NASDAQ |
Feb 13, 16:00
15.50
+0.36
(+2.38%)
After-Hours: 20:00
Tonix Pharmaceuticals EPS Diluted (Quarterly) : -3.587 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 2.455 |
| Amicus Therapeutics, Inc. | 0.0558 |
| Soligenix, Inc. | -0.5846 |
| Citius Oncology, Inc. | -0.0633 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -32.01M |
| Revenue (Quarterly) | 3.29M |
| Total Expenses (Quarterly) | 35.30M |
| Enterprise Value | -78.24M |
| Gross Profit Margin (Quarterly) | 44.44% |
| Profit Margin (Quarterly) | -972.9% |
| Earnings Yield | -6.52K% |
| Normalized Earnings Yield | -6517.44 |